DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

93.57 0.77 (0.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $93.57 0.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $93.08
Previous Close $92.80
Daily Range $92.40 - $94.00
52-Week Range $58.06 - $99.74
Market Cap $22.3B
P/E Ratio -46.63
Dividend (Yield) $0.00 (0.0%)
Volume 723,167
Average Daily Volume 1,357,300
Current FY EPS -$2.81

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary Rss Feed

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Nasdaq 100 Movers: VIP, VRTX

Guggenheim S&P 500 Equal Weight ETF Experiences Big Inflow

3 Drugs Stocks Dragging The Industry Down

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Anal

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog

Stock Market Today: Equities Rally Despite Poor Retail Earnings - Stocks in the News

Wednesday's ETF with Unusual Volume: PBP

S&P 500 Movers: VRTX, KMI

Nasdaq 100 Movers: ILMN, TSLA

10 stocks suffering the biggest cuts in earnings estimates

See More VRTX News...

VRTX's Top Competitors

VRTX $93.57 (0.83%)
Current stock: VRTX
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB